Skip to content

Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01957917
Enrollment
800
Registered
2013-10-08
Start date
2013-12-31
Completion date
2019-09-12
Last updated
2020-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, Food Insecurity, Antiretroviral Therapy

Brief summary

The importance of good nutrition and food security among people living with HIV infection (PLHIV) is widely recognized. In resource-constrained settings, food insecurity is increasingly recognized as an important barrier to retention in care and adherence to antiretroviral therapy (ART). However, there are few studies demonstrating that food and nutrition assistance programs can improve HIV-related outcomes. This study will address this gap by comparing the effectiveness of three models for short-term support for PLHIV. Food insecure women and men on ART will be randomized into one of three groups: 1) nutrition assessment and counseling (NAC) alone, 2) NAC plus food assistance, or 3) NAC plus cash transfers. The investigators will compare the effect of the three approaches on ART adherence and retention in care after 6, 12, and 24-36 months of follow-up. The investigators hypothesize that NAC plus short-term support in the form of food or cash assistance will result in better adherence to ART and retention in care than NAC alone, and that the effects of NAC plus food assistance will be the same as NAC plus cash assistance. The results from the study will provide evidence about which assistance modalities for PLHIV work best to improve ART adherence and retention in care, and under what conditions. This study will be conducted in Shinyanga Region, Tanzania, where approximately 17 percent of households have poor or borderline food consumption and 7.4 percent of people are living with HIV infection.

Detailed description

The investigators will randomize 785 food insecure women and men who recently initiated ART (determined with the Household Hunger Scale1) into one of three groups: 1) NAC alone , 2) NAC plus food assistance, or 3) NAC plus cash transfers. Food assistance will be a standard food ration consisting of maize flour, groundnuts, and beans. The cash transfer will be the equivalent value as the food ration (approximately $13 USD/month). Participants will receive the monthly food ration or cash transfer for up to six months if they continue to receive monthly HIV care (the standard of care). The investigators will compare the effect of NAC and food or cash assistance to the effect of NAC alone on ART adherence and retention in care at 6, 12, and 24-36 months (Objective #1). The investigators will also compare the effectiveness of NAC plus food assistance and NAC plus cash transfers to determine if their effects are the same (Objective #2).

Interventions

OTHERNAC (Nutritional Assessment and Counseling)

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Ministry of Health and Social Welfare, Tanzania
CollaboratorOTHER_GOV
University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. at least 18 years of age; 2. living with HIV infection; 3. initiated antiretroviral therapy (ART) for HIV infection in the last 90 days; 4. food insecure, as measured with the Household Hunger Scale; and 5. willing and able to provide written informed consent for the study.

Exclusion criteria

PLHIV who are severely malnourished (BMI\<18.5) will be excluded from the study, as these individuals require therapeutic food support (ready-to-use food products for nutritional recovery). In this study, we will enroll food insecure PLHIV who are at risk of malnutrition but are not severely malnourished (BMI\>18.5).

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline of Medication Possession Ratio (MPR) at 6 months and at 12 monthsBaseline, 6 months, 12 monthsART adherence will be measured with the medication possession ratio (MPR), the proportion of time an individual is in possession of \>1 ARV or prescription for ARV. MPR is computed as the number of days ARVs are prescribed or dispensed divided by the number of days in the interval, and has been shown to be associated with short-term virologic outcomes. We will determine the proportion of patients with MPR ≥95% in each of the study arms.

Secondary

MeasureTime frameDescription
Change from baseline in Food Security at 6 months and 12 monthsBaseline, 6 months, 12 monthsFood security will be measured with several validated scales: the Household Food Insecurity Access Scale (HFIAS), the Household Hunger Scale (HHS) and the Individual Dietary Diversity Scale (IDDS).
Change from baseline in Viral Suppression at 6 months and 12 monthsBaseline, 6 months, 12 monthsviral load \<400 copies/mL
Change from baseline in ART adherence at 6 months, 12 months, and 24-36 monthsBaseline, 6 months, 12 months, and 24-36 monthsProportion of patients who report taking at least 95% of prescribed doses in the previous month time frame. This will be measured by self-report.
Change from baseline in Weight at 6 months and 12 monthsBaseline, 6 months, 12 months
Change from baseline of Medication Possession Ratio (MPR) at 12-36 months12-36 monthsART adherence will be measured with the medication possession ratio (MPR), the proportion of time an individual is in possession of \>1 ARV or prescription for ARV. MPR is computed as the number of days ARVs are prescribed or dispensed divided by the number of days in the interval, and has been shown to be associated with short-term virologic outcomes. We will determine the proportion of patients with MPR ≥95% in each arm.
Retention in Care at 12-36 months12-36 monthsRetention in care will be assessed by number of participants in each arm that are still still in care at 12-36 months
Change from baseline in Body Mass Index (BMI) at 6 months and 12 monthsBaseline, 6, and 12 monthsbody weight in kilograms (kg) divided by height in meters squared

Other

MeasureTime frame
Change from baseline in ability to work/participation in the labor force at 6 months and 12 monthsBaseline, 6 months, 12 months

Countries

Tanzania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026